Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Enrolling by Invitation

Long-Term Follow-up Study

NCT05332054

Conditions: B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
Locations: University of Alabama Birmingham, Alabama, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Honor Health Research Institute Scottsdale, Arizona, United States

University of California Irvine Irvine, California, United States

View all 31 locations

View Trial Details

Enrolling by Invitation

Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network

NCT07445347

Conditions: Bevacizumab, Cardiovascular Abnormalities, Cardiovascular Diseases, +16 more
Locations: Centre hospitalier universitaire de Poitiers Poitiers, France

View Trial Details

Enrolling by Invitation

AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities

NCT07410403

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Zhongnan Hospital of Wuhan University Wuhan, Hubei, China

View Trial Details

Enrolling by Invitation

Palliative Care Needs of Children With Rare Diseases and Their Families

NCT06938542

Conditions: Abnormalities, Multiple, Anxiety Disorders, Arthrogryposis Congenita Multiplex With Intestinal Atresia, +84 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Enrolling by Invitation

A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

NCT04574076

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: AKH - Klin. Abt. f. Haematologie u. Haemostaseologie Vienna, Austria

UMHAT "Tsaritsa Yoanna-ISUL" Sofia, Bulgaria

KBC Zagreb, Rebro, Hemofilija centar Zagreb, Croatia

FN Brno odd. hematologie Brno, Czechia

View all 27 locations

View Trial Details

Enrolling by Invitation

Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases

NCT01852370

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Chronic Disease, +35 more
Locations: Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States

View Trial Details

Enrolling by Invitation

Feasibility and Safety of Blood-Flow-Restriction Training in Patients With Hemophilia

NCT07259356

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: University Hospital Bonn Bonn, North Rhine-Westphalia, Germany

View Trial Details

Enrolling by Invitation

Watch and Wait or Worry and Wait in Indolent Lymphoma

NCT07173790

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations: Samsung Medical Center Seoul, Gangnam-gu, South Korea

Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea

Seoul National University Hospital Seoul, Jongno-gu, South Korea

The Catholic University of Korea Seoul, Seocho-gu, South Korea

View Trial Details

Enrolling by Invitation

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

NCT07163260

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Novo Nordisk Investigational Site Bangalore, Karnataka, India

Novo Nordisk Investigational Site Kuala Lumpur, Malaysia

Novo Nordisk Investigational Site Seoul, South Korea

Novo Nordisk Investigational Site Bangkok, Thailand

View Trial Details

Enrolling by Invitation

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

NCT07210047

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Far Eastern Memorial Hospital Taipei, Taiwan

View Trial Details

Hemorrhagic Disorders

Hemorrhagic Disorders trial results

Related conditions